Type
Rheumatic manifestations in leprosy. Lancet (London, England). 1981;1(8221):648-9.
Type
. [Changes of amyloid-invaded intramucosal and muscularis mucosa nerves in the colon of leprosy. Observation with Golgi staining (author's transl)]. Nihon Rai Gakkai zasshi. 1981;50(1):39-45.
Type
. [Ultimate development of palliative surgery in leprosy]. Acta leprologica. 1981;(82):57-75.
Type
. Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE. Immunology. 1980;41(4):865-73.
Type
. Combined treatment for lepromatous leprosy. Leprosy review [Internet]. 1980;51(3):199-205. Available from: http://leprev.ilsl.br/pdfs/1980/v51n3/pdf/v51n3a01.pdf
Type
. Dapsone and anti-dapsone antibody in circulating immune complexes in leprosy patients. Lancet (London, England). 1980;1(8181):1309-11.
Type
. Immunological aspects of leprosy: ten years' activity at the Armauer Hansen Research Institute and Prospects for further work. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1980;48(2):193-205.
Type
. Fluorescent leprosy antibody absorption (FLA-ABS) test for detecting subclinical infection with Mycobacterium leprae. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1980;48(2):109-19.
Type
. HLA segregation of tuberculoid leprosy: confirmation of the DR2 marker. The Journal of infectious diseases. 1980;141(6):693-701.
Type
. In vitro stimulation of neutrophil motility in lepromatous leprosy. Leprosy review. 1980;51(2):195-7.